Gene · 4669
Papers3,421
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 3,421
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| IgA Nephropathy that Developed as an Immune-related Adverse Event of Pembrolizumab Complicated with Interstitial Nephritis. | Intern Med | 2022 | 34840226 | PubTator, text mining | PubMed |
| Successful Treatment of Nephrotic Syndrome Due to Collapsing Focal Segmental Glomerulosclerosis Accompanied by Acute Interstitial Nephritis. | Intern Med | 2022 | 34803098 | PubTator, text mining | PubMed |
| Biomarkers of cadmium exposure and renal function in estuarine adult villagers. | Int Arch Occup Environ Health | 2022 | 34773507 | PubTator, text mining | PubMed |
| Quantitative and qualitative analyses of urinary L-FABP for predicting acute kidney injury after emergency laparotomy. | J Anesth | 2022 | 34716487 | PubTator, text mining | PubMed |
| Identification of a Novel Pathogenic Variant in the NAGLU Gene in a Child with Neurodevelopmental Delay. | J Autism Dev Disord | 2022 | 34709531 | PubTator, text mining | PubMed |
| Immunoglobulin G4-related Pleuritis Complicated with Minimal Change Disease. | Intern Med | 2022 | 34483205 | PubTator, text mining | PubMed |
| Metabolic Differences between Unilateral and Bilateral Renal Stones and Their Association with Markers of Kidney Injury. | J Urol | 2022 | 34428923 | PubTator, text mining | PubMed |
| Dextran-based priming solution during cardiopulmonary bypass attenuates renal tubular injury-A secondary analysis of randomized controlled trial in adult cardiac surgery patients. | Acta Anaesthesiol Scand | 2022 | 34424995 | PubTator, text mining | PubMed |
| Current knowledge about biomarkers of acute kidney injury in liver cirrhosis. | Clin Mol Hepatol | 2022 | 34333958 | PubTator, text mining | PubMed |
| Tubulointerstitial nephritis and uveitis in Northern Ireland. | Eye (Lond) | 2022 | 34326494 | PubTator, text mining | PubMed |
| Renal Tubular Damage Marker, Urinary N-acetyl-β-D-Glucosaminidase, as a Predictive Marker of Hepatic Fibrosis in Type 2 Diabetes Mellitus. | Diabetes Metab J | 2022 | 34253010 | PubTator, text mining | PubMed |
| Comparing different markers of tubular dysfunction in transfusion-dependent thalassemia patients. | Int Urol Nephrol | 2022 | 34165679 | PubTator, text mining | PubMed |
| Nomogram to predict the progression of patients with primary membranous nephropathy and nephrotic syndrome. | Int Urol Nephrol | 2022 | 33909236 | PubTator, text mining | PubMed |
| Biomarkers for the diagnosis and management of heart failure. | Heart Fail Rev | 2022 | 33852110 | PubTator, text mining | PubMed |
| Phenotypic plasticity of fungal traits in response to moisture and temperature. | ISME Commun | 2021 | 36740602 | PubTator, text mining | PubMed |
| Menstruation Dysregulation and Endometriosis Development. | Front Reprod Health | 2021 | 36304032 | PubTator, text mining | PubMed |
Association between two common environmental toxicants (phthalates and melamine) and urinary markers of renal injury in the third trimester of pregnant women: The Taiwan Maternal and Infant Cohort Study (TMICS). | Chemosphere | 2021 | 35534976 | PubTator, text mining | PubMed |
| Bioengineered Kidney Models: Methods and Functional Assessments. | Function (Oxf) | 2021 | 35330622 | PubTator, text mining | PubMed |
| Developmental Exposure to Endocrine Disrupting Chemicals and Its Impact on Cardio-Metabolic-Renal Health. | Front Toxicol | 2021 | 35295127 | PubTator, text mining | PubMed |
| Cerebro-Cardiovascular Risk, Target Organ Damage, and Treatment Outcomes in Primary Aldosteronism. | Front Cardiovasc Med | 2021 | 35187110 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4669/papers?page=35